Relation of a novel fibrosis marker and post-myocardial infarction left ventricular ejection fraction in revascularized patients.

MLA

Kilci, Hakan, et al. “Relation of a Novel Fibrosis Marker and Post-Myocardial Infarction Left Ventricular Ejection Fraction in Revascularized Patients.” Biomarkers in Medicine, vol. 15, no. 17, Dec. 2021, pp. 1651–58. EBSCOhost, https://doi.org/10.2217/bmm-2021-0003.

APA

Kilci, H., Altınbilek, E., Çetinkal, G., Sığırcı, S., Koçaş, B. B., Yıldız, S. S., & Kılıçkesmez, K. O. (2021). Relation of a novel fibrosis marker and post-myocardial infarction left ventricular ejection fraction in revascularized patients. Biomarkers in Medicine, 15(17), 1651–1658. https://doi.org/10.2217/bmm-2021-0003

Chicago

Kilci, Hakan, Ertuğrul Altınbilek, Gökhan Çetinkal, Serhat Sığırcı, Betül B Koçaş, Süleyman S Yıldız, and Kadriye Orta Kılıçkesmez. 2021. “Relation of a Novel Fibrosis Marker and Post-Myocardial Infarction Left Ventricular Ejection Fraction in Revascularized Patients.” Biomarkers in Medicine 15 (17): 1651–58. doi:10.2217/bmm-2021-0003.